ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Mallinckrodt’s Niemann-Pick Type C drug fails to hit trial target
UK-based Mallinckrodt has revealed that its experimental therapy for Niemann-Pick Type C failed to hit targets in a recently completed registration trial.
-
Mallinckrodt’s Niemann-Pick Type C drug fails to hit trial target
November 09, 2018UK-based Mallinckrodt has revealed that its experimental therapy for Niemann-Pick Type C failed to hit targets in a recently completed registration trial.
Pharma Sources Insight January 2025
